ストックスクリーナーアプリを入手
37.37
3.29%
-1.27
アフターアワーズ：
37.50
0.13
+0.35%
前日終値:
$38.64
開ける：
$38.525
24時間の取引高:
629.07K
Relative Volume:
1.41
時価総額：
$1.07B
収益：
-
当期純損益:
$-69.47M
株価収益率:
-6.6764
EPS:
-5.5973
ネットキャッシュフロー:
$-73.92M
1週間 パフォーマンス:
-3.04%
1か月 パフォーマンス:
+18.18%
6か月 パフォーマンス:
+75.53%
1年 パフォーマンス:
+69.86%
1日の値動き範囲:
$36.81
$39.50
1週間の範囲:
$36.81
$41.26
52週間の値動き範囲:
$16.54
$41.70
Lenz Therapeutics Inc Stock (LENZ) Company Profile
名前
Lenz Therapeutics Inc
セクター
電話
858-925-7000
住所
201 LOMAS SANTA FE DRIVE, SUITE 300, SOLANA BEACH
LENZ を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
LENZ
Lenz Therapeutics Inc
|
37.37 | 1.10B | 0 | -69.47M | -73.92M | -5.5973 |
|
VRTX
Vertex Pharmaceuticals Inc
|
389.08 | 99.27B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
586.96 | 62.28B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.18 | 59.14B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
707.96 | 43.34B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
300.14 | 36.72B | 3.81B | -644.79M | -669.77M | -6.24 |
Lenz Therapeutics Inc Stock (LENZ) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-04-14 | 再開されました | Piper Sandler | Overweight |
| 2025-03-18 | 開始されました | TD Cowen | Buy |
| 2024-09-27 | 開始されました | Raymond James | Outperform |
| 2024-08-12 | 開始されました | H.C. Wainwright | Buy |
| 2024-04-15 | 開始されました | Leerink Partners | Outperform |
| 2024-04-15 | 開始されました | William Blair | Outperform |
| 2024-04-10 | 開始されました | Citigroup | Buy |
| 2024-03-27 | 開始されました | Piper Sandler | Overweight |
| 2023-02-23 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2023-02-23 | ダウングレード | Cantor Fitzgerald | Overweight → Neutral |
| 2023-02-23 | ダウングレード | Cowen | Outperform → Market Perform |
| 2023-01-25 | ダウングレード | BTIG Research | Buy → Neutral |
| 2023-01-18 | ダウングレード | BofA Securities | Buy → Neutral |
| 2023-01-06 | ダウングレード | BMO Capital Markets | Outperform → Market Perform |
| 2023-01-06 | ダウングレード | SVB Leerink | Outperform → Mkt Perform |
| 2022-09-15 | 開始されました | Cantor Fitzgerald | Overweight |
| 2022-06-17 | 開始されました | BMO Capital Markets | Outperform |
| 2022-04-14 | 開始されました | BTIG Research | Buy |
| 2022-03-22 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2022-02-18 | 開始されました | RBC Capital Mkts | Sector Perform |
| 2021-07-20 | 開始されました | Morgan Stanley | Overweight |
| 2021-07-20 | 開始されました | SVB Leerink | Outperform |
すべてを表示
Lenz Therapeutics Inc (LENZ) 最新ニュース
Multi factor analysis applied to LENZ Therapeutics Inc.Inflation Watch & Weekly Top Stock Performers List - Newser
LENZ Therapeutics : Corporate Presentation - MarketScreener
Why LENZ Therapeutics Inc. is moving today2025 Price Momentum & Target Return Focused Stock Picks - Newser
What the charts say about LENZ Therapeutics Inc. todayMarket Growth Review & Fast Exit and Entry Trade Guides - Newser
How institutional ownership impacts LENZ Therapeutics Inc. stock2025 EndofYear Setup & Verified Chart Pattern Signals - Newser
Should you hold or exit LENZ Therapeutics Inc. nowJuly 2025 Macro Moves & Community Supported Trade Ideas - Newser
LENZ Therapeutics Inc. stock outlook for YEAR2025 Valuation Update & Reliable Volume Spike Trade Alerts - Newser
How to manage a losing position in LENZ Therapeutics Inc.Earnings Risk Report & Community Verified Swing Trade Signals - Newser
Developing predictive dashboards with LENZ Therapeutics Inc. data2025 Price Momentum & Scalable Portfolio Growth Methods - Newser
Has LENZ Therapeutics Inc. found a price floor2025 Market Outlook & Momentum Based Trading Ideas - Newser
What MACD signals say about LENZ Therapeutics Inc.2025 Geopolitical Influence & Expert-Curated Trade Recommendations - Newser
Relative strength of LENZ Therapeutics Inc. in sector analysisShort Setup & Capital Efficient Trade Techniques - Newser
Using data tools to time your LENZ Therapeutics Inc. exitPortfolio Gains Report & Consistent Profit Trade Alerts - Newser
What makes LENZ Therapeutics Inc. stock price move sharplyPortfolio Value Summary & AI Based Buy/Sell Signal Reports - Newser
Detecting support and resistance levels for LENZ Therapeutics Inc.July 2025 Summary & Low Risk High Reward Ideas - Newser
Trend analysis for LENZ Therapeutics Inc. this weekWeekly Stock Report & Safe Swing Trade Setups - Newser
Real time breakdown of LENZ Therapeutics Inc. stock performanceGlobal Markets & Stepwise Trade Execution Plans - Newser
Using data models to predict LENZ Therapeutics Inc. stock movementWeekly Gains Report & Capital Efficiency Focused Strategies - Newser
Investors Hope for Bounce in LENZ Therapeutics Inc. After Selloff getLinesFromResByArray error: size == 0 - sisain.net
Full technical analysis of LENZ Therapeutics Inc. stock2025 Risk Factors & AI Forecasted Entry and Exit Points - Newser
LENZ Therapeutics Inc.’s volatility index tracking explainedJuly 2025 Update & High Yield Stock Recommendations - Newser
Analyzing LENZ Therapeutics Inc. with risk reward ratio chartsWeekly Risk Report & Fast Exit Strategy with Risk Control - Newser
How to build a dashboard for LENZ Therapeutics Inc. stock2025 Retail Activity & Low Risk Entry Point Tips - Newser
What MACD and RSI say about LENZ Therapeutics Inc.Market Sentiment Summary & Free Weekly Chart Analysis and Trade Guides - Newser
LENZ Therapeutics to Present VIZZ at Upcoming Investor and Medical Conferences. - AInvest
First FDA-Approved Aceclidine Eye Drops: LENZ Therapeutics to Present VIZZ Data at Multiple Fall Conferences - Stock Titan
How much upside does LENZ Therapeutics Inc. haveTrade Signal Summary & Daily Stock Trend Watchlist - sundaytimes.kr
Will LENZ Therapeutics Inc. stock recover after recent drop2025 Breakouts & Breakdowns & Risk Managed Investment Strategies - Newser
Will LENZ Therapeutics Inc. benefit from macro trendsForecast Cut & Growth-Oriented Investment Plans - Newser
Has LENZ Therapeutics Inc. Stock Ever Crashed Historical Volatility Review2025 Risk Factors & Growth Focused Investment Plans - Newser
LENZ Therapeutics stock price target raised to $56 from $48 at H.C. Wainwright By Investing.com - Investing.com Nigeria
LENZ Therapeutics stock price target raised to $56 from $48 at H.C. Wainwright - Investing.com
LENZ Therapeutics Inc. Stocks Attracting Dip BuyersJuly 2025 Rallies & High Conviction Buy Zone Alerts - 더경남뉴스
LENZ Therapeutics' Vizz Approval Sets Stage for Commercial Potential - AInvest
Will FDA Approval of Vizz Eye Drops Change LENZ Therapeutics' (LENZ) Narrative? - Yahoo Finance
What high frequency data says about LENZ Therapeutics Inc.2025 Top Decliners & Step-by-Step Swing Trade Plans - Newser
News impact scoring models applied to LENZ Therapeutics Inc.Market Sentiment Report & Real-Time Buy Signal Notifications - Newser
Lenz Therapeutics Inc (LENZ) 財務データ
収益
当期純利益
現金流量
EPS
0.98%
8.06%
大文字化:
|
ボリューム (24 時間):